USADA serves UFC’s Bruno Arruda da Silva a two-year suspension
The UFC debut for one Bruno Arruda da Silva is on hold for at least a year.
On Monday, June 22, Arruda da Silva received a two-year suspension from the U.S. Anti-Doping Agency. It stems from testing positive for boldenone in an out-of competition sample collected on May 27, 2019.
Boldenone is a non-specified substance in the class of anabolic steroids. It is banned at all times according to the UFC anti-doping policy UFC prohibited list.
Arruda Da Silva was originally pulled for an undisclosed reason from his middleweight matchup with Deron Winn at UFC on ESPN +12 this Saturday, June 27.
Arruda da Silva attempted to reduce the length of the suspension after bringing his case to an independent mediator on May 27. He was unable to make a plausible argument for the failed drug test.
He also and never mentioned his use of Boldenone prior to joining the UFC. The suspension began on June 14, 2019, making him ineligible until June 14, 2021.
The 30-year-old Bruno Arruda da Silva is on a four-fight TKO win streak. He most recently defeated Artem Frolov in the fourth round at M-1 Challenge 98 in November 2018.
Stay locked to MyMMANews for more information.
